Aquarius Surgical Technologies (ASTI) AI Stock Analysis

• Market Cap: C$413.99K
• Dividend Yield: N/A
• Average Volume (3M): 6.90K
• Price to Earnings (P/E): 0.2
• Beta (1Y): 1.27
• Revenue Growth: -57.16%
• EPS Growth: 2.93%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.02
• Shares Outstanding: 27,599,173
• 10 Day Avg. Volume: 4,405
• 30 Day Avg. Volume: 6,901
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.10
• Price to Sales (P/S): 6.05
• P/FCF Ratio: -1.44
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: C$0.02 ▲(50.00% Upside)
• Action: Reiterated Date: 03/11/26
• Date: Action: Reiterated 03/11/26

The score is driven down primarily by very weak financial performance (losses, negative equity, and negative operating/free cash flow). Technicals are mixed—above key moving averages with a positive MACD, but an overbought RSI elevates downside risk. Valuation looks optically cheap on P/E, but it is not enough to offset the financial and liquidity concerns.

Positive Factors

Industry Exposure - Medical Devices

Operating in the medical devices sector provides structural demand driven by healthcare spending, aging populations, and recurring capital replacement cycles. These industry characteristics support durable revenue opportunities and long-term market relevance independent of short-term cycles.

Positive Return on Equity (reported)

A reported positive ROE indicates the company can generate accounting returns on its equity base; even though driven by negative equity, it signals operating leverage exists. If balance sheet repair occurs, the company could convert operating performance into sustainable shareholder returns.

Free cash flow aligns with net income

FCF matching net income suggests earnings are backed by cash flow rather than large non‑cash adjustments, which supports earnings quality. While flows are negative in absolute terms, parity reduces risk of hidden accruals and aids assessment of recovery trajectories.

Negative Factors

Negative Stockholders' Equity

Liabilities exceeding assets indicate impaired solvency and limited financial flexibility. Negative equity constrains access to debt/equity markets, raises default risk, and can force asset sales or dilutive capital raises, undermining long-term strategic investments.

Sustained Revenue Decline

A persistent top‑line decline reduces scale economies and pressures gross and operating margins. Losing revenue momentum in a device business weakens pricing power, increases per‑unit overhead, and makes investment in product development and commercialization harder to sustain.

Negative Operating and Free Cash Flow

Persistent negative operating and free cash flows drain liquidity and force reliance on external financing. Over months, this limits R&D, regulatory submissions, and sales expansion, increases refinancing/dilution risk, and can materially impair long‑term competitiveness.

Aquarius Surgical Technologies Business Overview & Revenue Model

Company Description

Aquarius Surgical Technologies (ASTI) is a pioneering company in the medical device sector, specializing in advanced surgical solutions designed to enhance patient outcomes and streamline surgical procedures. The company focuses on developing innovative technologies for minimally invasive surgeries, including a range of surgical instruments, robotic systems, and imaging solutions that cater to various medical fields such as orthopedics, cardiology, and general surgery. ASTI is committed to improving surgical efficiency and safety through its cutting-edge products and comprehensive support services.

Aquarius Surgical Technologies Financial Statement Overview

Summary

Financial statements indicate severe weakness: revenue declined (-17.1%), profitability is negative (net margin -12.8% with negative EBIT/EBITDA margins), the balance sheet shows negative stockholders’ equity (liabilities exceeding assets), and operating/free cash flow are negative, signaling liquidity strain.

Income Statement

Aquarius Surgical Technologies has experienced declining revenues with a negative revenue growth rate of -17.1% in the most recent year. The company also shows negative profit margins, with a net profit margin of -12.8%, indicating significant losses. The EBIT and EBITDA margins are also negative, reflecting operational inefficiencies. Overall, the income statement reveals financial struggles with declining revenues and persistent losses.

Balance Sheet

The balance sheet shows a concerning financial position with negative stockholders' equity, resulting in a negative debt-to-equity ratio. This indicates that liabilities exceed assets, posing a risk to financial stability. The return on equity is positive, but this is due to the negative equity base rather than profitability. Overall, the balance sheet reflects high leverage and financial instability.

Cash Flow

The cash flow statement shows negative operating and free cash flows, indicating cash outflows from operations. The free cash flow to net income ratio is 1.0, suggesting that cash flows are aligned with net losses. However, the negative operating cash flow coverage ratio highlights challenges in covering operational expenses. Overall, the cash flow statement reflects liquidity challenges and insufficient cash generation.

Breakdown	Jun 2025	Jun 2023	Mar 2022	Jun 2020	Mar 2019
Income Statement
Total Revenue	91.20K	205.25K	327.66K	958.74K	393.38K
Gross Profit	47.31K	132.85K	130.30K	378.25K	161.41K
EBITDA	-832.81K	-456.62K	-611.35K	-1.18M	-1.24M
Net Income	-1.17M	-757.66K	-859.20K	-1.61M	-1.59M
Balance Sheet
Total Assets	1.95M	574.44K	894.98K	1.66M	1.72M
Cash, Cash Equivalents and Short-Term Investments	7.56K	107.38K	158.19K	105.19K	125.44K
Total Debt	6.47M	4.04M	3.24M	2.02M	2.02M
Total Liabilities	7.72M	5.18M	4.11M	2.35M	2.18M
Stockholders Equity	-5.77M	-4.61M	-3.21M	-689.15K	-453.90K
Cash Flow
Free Cash Flow	-383.29K	-256.92K	-117.38K	-1.07M	-2.17M
Operating Cash Flow	-383.29K	-252.56K	-112.16K	-951.17K	-1.35M
Investing Cash Flow	-1.80M	-4.36K	-5.22K	-86.99K	-818.55K
Financing Cash Flow	2.08M	242.29K	129.59K	1.02M	1.72M

Aquarius Surgical Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.01
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ASTI, the sentiment is Positive. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 81.83 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:ASTI.

Aquarius Surgical Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
VPT	50 Neutral	C$20.64M	-5.28	106.68%	―	28.59%	23.46%
ASTI	46 Neutral	C$413.99K	0.24	4.41%	―	-57.16%	2.93%
ASG	46 Neutral	C$21.07M	-29.60	-31.12%	―	9.71%	-118.02%
PRN	46 Neutral	C$282.36M	-5.47	-85.73%	―	72.03%	-1.47%
PINK	42 Neutral	C$56.75M	-1.50	-181.70%	―	209.29%	35.38%